Lupin Limited
LUPIN
Rank in Stocks
#2084
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Share Price
$21.43
Market Cap
$9.80B
Change (1 day)
-1.22%
Change (1 year)
-2.76%
Country
IN
Trade Lupin Limited (LUPIN)
Category
Healthcare
Operating Margin for Lupin Limited (LUPIN)
Operating Margin as of October 2026 TTM: 25.22%
According to Lupin Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 25.22%. At the end of 2024 the company had an Operating Margin of 38.88%.
Operating Margin history for Lupin Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 25.22% | -39.59% |
| 2025 | 41.75% | 7.38% |
| 2024 | 38.88% | 671.43% |
| 2023 | 5.04% | -36.04% |
| 2022 | 7.88% | -30.94% |
| 2021 | 11.41% | 26.08% |
| 2020 | 9.05% | -24.46% |
| 2019 | 11.98% | -9.99% |
| 2018 | 13.31% | -41.73% |
| 2017 | 22.84% | -3.26% |
| 2016 | 23.61% | -10.74% |
| 2015 | 26.45% | 3.77% |
| 2014 | 25.49% | 22.08% |
| 2013 | 20.88% | 18.97% |
| 2012 | 17.55% | -2.66% |
| 2011 | 18.03% | -1.53% |
| 2010 | 18.31% | 5.41% |
| 2009 | 17.37% | -18.60% |
| 2008 | 21.34% | -3.35% |
| 2007 | 22.08% | 45.74% |
| 2006 | 15.15% | 55.07% |
| 2005 | 9.77% | -51.27% |
| 2004 | 20.05% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.09% |
IN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.